Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Pulmonary Disease, Chronic Obstructive 1Lymphoma, Follicular 1

Interventions

Standard of Care 2vilanterol 1tocilizumab 1Tiotropium Bromide 1Surgical Procedures, Operative 1Salmeterol Xinafoate 1Rehabilitation 1Practice Guidelines as Topic 1Immunoglobulin G 1Fluticasone-Salmeterol Drug Combination 1Fluticasone 1Educational Status 1Disulfides 1Albuterol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Pulmonary Disease, Chronic Obstructive × Fluticasone × Clear all
NCT03745261 2018-11-19

Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD

Henan University of Traditional Chinese Medicine

Phase 3 Unknown
240 enrolled
Lymphoid

Lymphoma, Follicular, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡